• Subscribe
  • Newsfeed
  • About
Announce News

Modi Ventures

To add a bio or update investment portfolio, please click update information.

Investment Portfolio

    Brainomix lands a £4.8m Series C extension led by Parkwalk Advisors and Hostplus for AI medical imaging in stroke and lung fibrosisBrainomix lands a £4.8m Series C extension led by Parkwalk Advisors and Hostplus for AI medical imaging in stroke and lung fibrosis
    Brainomix
    24 Feb 2026

    Brainomix lands a £4.8m Series C extension led by Parkwalk Advisors and Hostplus for AI medical imaging in stroke and lung fibrosis

    Brainomix develops medical imaging software that helps clinicians assess stroke and lung fibrosis using automated image analysis. Its platforms support diagnosis and treatment decisions by analysing scans and providing clinical insights at the point of care.

    Ignota Labs raises £5.5m seed led by Montage Ventures and AIX Ventures to turn around failed drugsIgnota Labs raises £5.5m seed led by Montage Ventures and AIX Ventures to turn around failed drugs
    Ignota Labs
    26 Feb 2025

    Ignota Labs raises £5.5m seed led by Montage Ventures and AIX Ventures to turn around failed drugs

    Ignota Labs applies AI-driven drug discovery to rescue and redevelop failed drug candidates, identifying and resolving safety issues so promising therapies can be revived and progressed back into clinical development.

Modi Ventures
    • Health
    • Life Sciences
  • 1(12 months)
  • modivc.com
  • Update Information

More venture news

  • Brainomix lands a £4.8m Series C extension led by Parkwalk Advisors and Hostplus for AI medical imaging in stroke and lung fibrosis
    Brainomix
    24 Feb 2026

    Brainomix lands a £4.8m Series C extension led by Parkwalk Advisors and Hostplus for AI medical imaging in stroke and lung fibrosis

    ExtensionHealth
  • Centauri Therapeutics secures a £6m Series A extension from AMR Action Fund to target drug-resistant bacterial infections with immunotherapy
    Centauri Therapeutics
    24 Feb 2026

    Centauri Therapeutics secures a £6m Series A extension from AMR Action Fund to target drug-resistant bacterial infections with immunotherapy

    ExtensionLife Sciences
  • SurrealDB secures a £17m Series A extension led by Chalfen Ventures and Begin Capital for its multi-model database for AI
    SurrealDB
    17 Feb 2026

    SurrealDB secures a £17m Series A extension led by Chalfen Ventures and Begin Capital for its multi-model database for AI

    ExtensionEnterprise

Sign-up to our newsletter

The UK Weekly email covers every VC round from last week, firms that are hiring, and much more

Soapbox Ventures Limited © 2026

Disclaimer

Privacy Policy

LinkedIn

Announce

  • Share your story

General

  • Read the latest
  • About Soapbox

Information not up to date?

Get in touch

Soapbox Ventures Limited © 2026

Disclaimer

Privacy Policy

LinkedIn